1610359-11-9

Basic information

• Product Name: (2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methanol
• Synonyms: (2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methanol
• CAS NO: 1610359-11-9
• Molecular Weight: 377.778
• Mol File: 1610359-11-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methanol(1610359-11-9)
• EPA Substance Registry System: (2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methanol(1610359-11-9)

Safety Data

• Hazardous Substances Data: 1610359-11-9(Hazardous Substances Data)

Upstream product

• 179899-07-1 4-fluoro-2-methoxyphenylboronic acid 
• 884494-49-9 2-chloro-5-fluoro-4-iodopyridine 
• 101990-69-6 (2,6-dichloropyridin-4-yl)methanol 
• 1602486-07-6 5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 
• 1602486-03-2 2-chloro-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridine 

Downstream Products

• 1610358-67-2 (rac)-N-{6-chloro-4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 
• 1610359-13-1 N-[6-chloro-4-(chloromethyl)pyridin-2-yl]-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 
• 1610359-12-0 N-{6-chloro-4-[(methylsulfanyl)methyl]pyridin-2-yl}-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 
• 1610359-14-2 (rac)-N-{[(2-chloro-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methyl](methyl)-λ⁴-sulfanylidene}-2,2,2-trifluoroacetamide 

Relevant articles and documents

5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).